Use of inotuzumab-ozogamicin in a child with Down syndrome and refractory B-cell precursor acute lymphoblastic leukemia

被引：4
|
作者：
Murillo, Laura [1 ]
Luis Dapena, Jose [1 ]
Velasco, Pablo [1 ]
Diaz de Heredia, Cristina [1 ]
机构：
[1] Hosp Univ Vall dHebron, Serv Oncol & Hematol Pediat, Passeig Vall dHebron 119-129, Barcelona 08035, Spain
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷 / 04期
关键词：
MINIMAL RESIDUAL DISEASE; PROGNOSTIC-FACTORS; PEDIATRIC-PATIENTS; TRANSPLANTATION;
D O I：
10.1002/pbc.27562
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Inotuzumab ozogamicin in the treatment of B-cell acute lymphoblastic leukemia
    Thomas, Xavier
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (06) : 871 - 878
  • [2] Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia
    Thota, Swapna
    Advani, Anjali
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (05) : 425 - 434
  • [3] Inotuzumab ozogamicin in B-cell precursor acute lymphoblastic leukemia: efficacy, toxicity, and practical considerations
    Rubinstein, Jeremy D. D.
    O'Brien, Maureen M. M.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [4] PHARMACOECONOMIC PERSPECTIVES ON THE USE OF INOTUZUMAB OZOGAMICIN IN THE TREATMENT OF RELAPSED OR REFRACTORY FORMS OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Kolbin, A.
    Velum, I
    Balykina, Y.
    Proskurin, M.
    VALUE IN HEALTH, 2019, 22 : S501 - S501
  • [5] Inotuzumab Ozogamicin in Indian Patients with B-Cell Acute Lymphoblastic Leukemia
    Borah, Pronamee
    Mohan, Vivek
    Jain, Sachin
    Capoor, Varun
    Naithani, Rahul
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024,
  • [6] Inotuzumab Ozogamicin Salvage Monotherapy for the Treatment of Relapsed/Refractory Acute B-Cell Lymphoblastic Leukemia
    Darcin, Tahir
    Yigenoglu, Tugce Nur
    Sahin, Derya
    Bakirtas, Mehmet
    Basci, Semih
    Merdin, Alparslan
    Yildiz, Jale
    Ulu, Bahar Uncu
    Tetik, Aysegul
    Iskender, Dicle
    Cakar, Merih Kizil
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S192 - S193
  • [7] Pediatric Studies with Inotuzumab Ozogamicin for B-cell Acute Lymphoblastic Leukemia
    Pennesi, Edoardo
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 : 8 - 11
  • [8] Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia
    Uy, Natalie
    Nadeau, Michelle
    Stahl, Maximilian
    Zeidan, Amer M.
    JOURNAL OF BLOOD MEDICINE, 2018, 9 : 67 - 74
  • [9] Inotuzumab-Ozogamicin induces remissions and enables allogeneic SCT in patients with Blinatumomab-refractory B-precursor acute lymphoblastic leukemia
    Buecklein, Veit
    Fraccaroli, Alessia
    Prevalsek, Dusan
    Haebe, Sarah
    Schulz, Christoph
    Zoellner, Anna-Katharina
    Spiekermann, Karsten
    Subklewe, Marion
    Tischer, Johanna
    BONE MARROW TRANSPLANTATION, 2018, 53 : 170 - 171
  • [10] BUDGET IMPACT ANALYSIS OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN THE NETHERLANDS
    van Oostrum, I
    De Lameillieure, K.
    Russell-Smith, T. A.
    VALUE IN HEALTH, 2020, 23 : S444 - S444
12345